Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Japan Tissue Engineering Co., Ltd. ( (JP:7774) ) has shared an update.
Japan Tissue Engineering Co., Ltd. reported a decline in net sales and profits for the three months ended June 30, 2025, with net sales at 426 million yen, a 3.6% decrease from the previous year. Despite the current financial challenges, the company forecasts a potential increase in net sales and profits for the fiscal year ending March 31, 2026, indicating a cautious optimism amidst external environmental factors impacting its business.
More about Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company is listed on the Tokyo Stock Exchange and is known for its innovative tissue engineering solutions.
Average Trading Volume: 147,693
Technical Sentiment Signal: Buy
Current Market Cap: Yen25.54B
Find detailed analytics on 7774 stock on TipRanks’ Stock Analysis page.